H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes
- PMID: 25446652
- DOI: 10.1016/j.biochi.2014.11.004
H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes
Abstract
High concentrations of glucose induce cardiomyocyte apoptosis, and contribute to diabetic cardiomyopathy. Relaxin-2 and relaxin-3 are two members of the relaxin peptide family that are cardioprotective. However, it remains unknown whether relaxin-2 or relaxin-3 can regulate apoptosis in high glucose treated-neonatal rat ventricular myocytes (NRVMs). In cultured NRVMs, 33 mmol/l high glucose (HG) increased apoptosis in a time-dependent manner. HG-increased the protein expression of cleaved caspase-8 and -9, two initiators of the extrinsic and intrinsic pathways of apoptosis, Caspase-3 was attenuated by human recombinant relaxin-2 (H2 relaxin) or relaxin-3 (H3 relaxin), indicating that H2 and H3 relaxin inhibited HG-induced apoptosis. Furthermore, endoplasmic reticulum stress (ERS) markers CHOP and caspase-12 were markedly increased in HG-treated NRVMs, leading to apoptosis; this effect was also effectively attenuated by H2 relaxin or H3 relaxin. Treatment of NRVMs with HG reduced autophagy which cannot be adjusted by H2 relaxin or H3 relaxin. In conclusion, HG-induced apoptosis in NRVMs was mediated, in part, by the activation of the extrinsic and intrinsic pathways of apoptosis and ERS, all inhibited by H2 relaxin or H3 relaxin.
Keywords: Apoptosis; Endoplasmic reticulum stress; H2 relaxin; H3 relaxin; High glucose.
Copyright © 2014 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.
Similar articles
-
Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes.Endocrinology. 2007 Apr;148(4):1582-9. doi: 10.1210/en.2006-1324. Epub 2007 Jan 4. Endocrinology. 2007. PMID: 17204550
-
Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress.J Cardiovasc Pharmacol. 2013 Aug;62(2):143-53. doi: 10.1097/FJC.0b013e31829521af. J Cardiovasc Pharmacol. 2013. PMID: 23609327
-
Tiron ameliorates high glucose-induced cardiac myocyte apoptosis by PKCδ-dependent inhibition of osteopontin.Clin Exp Pharmacol Physiol. 2017 Jul;44(7):760-770. doi: 10.1111/1440-1681.12762. Clin Exp Pharmacol Physiol. 2017. PMID: 28394420
-
Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation.Int J Cardiol. 2013 Sep 20;168(1):270-80. doi: 10.1016/j.ijcard.2012.09.080. Epub 2012 Nov 13. Int J Cardiol. 2013. PMID: 23158927
-
Relaxin in liver transplantation: A personal perspective.Mol Cell Endocrinol. 2019 May 1;487:75-79. doi: 10.1016/j.mce.2019.02.022. Epub 2019 Mar 3. Mol Cell Endocrinol. 2019. PMID: 30840848 Free PMC article. Review. No abstract available.
Cited by
-
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives.Front Physiol. 2017 Aug 18;8:599. doi: 10.3389/fphys.2017.00599. eCollection 2017. Front Physiol. 2017. PMID: 28868039 Free PMC article. Review.
-
H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose.J Cell Mol Med. 2018 Mar;22(3):1816-1825. doi: 10.1111/jcmm.13464. Epub 2018 Jan 5. J Cell Mol Med. 2018. PMID: 29314607 Free PMC article.
-
Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes.Front Pharmacol. 2018 May 15;9:501. doi: 10.3389/fphar.2018.00501. eCollection 2018. Front Pharmacol. 2018. PMID: 29867503 Free PMC article. Review.
-
Relaxin-3 Ameliorates Diabetic Cardiomyopathy by Inhibiting Endoplasmic Reticulum Stress.Comput Math Methods Med. 2022 Sep 27;2022:9380283. doi: 10.1155/2022/9380283. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Nov 29;2023:9878047. doi: 10.1155/2023/9878047 PMID: 36203531 Free PMC article. Retracted.
-
Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes.Endocrine. 2018 Apr;60(1):103-111. doi: 10.1007/s12020-018-1534-3. Epub 2018 Feb 6. Endocrine. 2018. PMID: 29411306
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials